Regeneron Pharmaceuticals... (REGN)

NASDAQ: REGN · Real-Time Price · USD

588.60

-10.16 (-1.70%)

At close: May 01, 2025, 3:59 PM

591.40

0.48%

After-hours: May 01, 2025, 07:42 PM EDT

Regeneron Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	4.41B	3.95B	4.34B	8.08B	3.51B	2.12B	2.44B	1.2B	895.52M
Depreciation & Amortization	482.9M	421M	341.4M	286.2M	235.9M	210.3M	148.2M	145.47M	104.75M
Stock-Based Compensation	982.8M	885M	725M	601.7M	432M	464.3M	427.4M	507.28M	559.88M
Other Working Capital	-179.7M	-82.2M	-116.2M	-360.9M	263M	163.6M	-250.2M	-226.43M	267.81M
Other Non-Cash Items	-82.2M	266.3M	599.8M	181.7M	-135M	-29.3M	12.1M	-36.9M	485.7M
Deferred Income Tax	-757.3M	-837.8M	-746.4M	-147.1M	75.6M	-130.6M	-140M	318.81M	-360.08M
Change in Working Capital	-618.3M	-94.1M	-243.3M	-1.92B	-1.5B	-200.5M	-697M	-926.53M	228.19M
Operating Cash Flow	4.42B	4.59B	5.01B	7.08B	2.62B	2.43B	2.2B	1.31B	1.49B
Capital Expenditures	-755.9M	-926.4M	-590.1M	-551.9M	-614.6M	-429.6M	-383.1M	-272.6M	-511.9M
Cash Acquisitions	-16.5M	-54.9M	-230.3M	551.9M	614.6M	429.6M	1.07B	n/a	n/a
Purchase of Investments	-16.62B	-11.65B	-7.49B	-7.05B	-3.24B	-3.2B	-1.85B	-1.28B	-809.42M
Sales Maturities Of Investments	15.03B	9.44B	5.55B	2.22B	3.79B	1.6B	775.6M	544.58M	274.46M
Other Investing Acitivies	-105.6M	-926.4M	-1.03B	-551.9M	-614.6M	-429.6M	-1.08B	-732.6M	-534.9M
Investing Cash Flow	-2.47B	-3.19B	-3.78B	-5.38B	-70.6M	-2.03B	-1.46B	-1.01B	-1.05B
Debt Repayment	n/a	n/a	n/a	n/a	1.98B	n/a	n/a	37.1M	-40.6M
Common Stock Repurchased	-3.63B	-2.94B	-2.53B	-2.68B	-6.53B	-463.9M	-191.6M	-301.7M	-143.2M
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-33.4M	n/a	-445.7M	-1.03B	2.58B	-188M	-187.2M	n/a	-516.59M
Financial Cash Flow	-2.2B	-1.79B	-1.01B	-1.01B	-1.97B	-252.1M	-77.1M	-24.4M	-700.39M
Net Cash Flow	-248.8M	-381.6M	221.3M	690.8M	577M	150.1M	655M	277.53M	-273.9M
Free Cash Flow	3.66B	3.67B	4.42B	6.53B	2B	2B	1.81B	1.03B	974M